中华实验外科杂志
中華實驗外科雜誌
중화실험외과잡지
CHINESE JOURNAL OF EXPERIMENTAL SURGERY
2015年
8期
1869-1871
,共3页
刘宇%黄群爱%刘瑞磊%姜华%吴珏堃%李玺
劉宇%黃群愛%劉瑞磊%薑華%吳玨堃%李璽
류우%황군애%류서뢰%강화%오각곤%리새
射频消融%胞嘧啶鸟嘌呤寡脱氧核苷酸%乳腺癌%免疫治疗
射頻消融%胞嘧啶鳥嘌呤寡脫氧覈苷痠%乳腺癌%免疫治療
사빈소융%포밀정조표령과탈양핵감산%유선암%면역치료
Ablation%Cytosine phosphate guanine oligodeoxyribonucleotide%Breast cancer%Immunotherapy
目的 观察射频消融联合瘤周注射胞嘧啶鸟嘌呤寡脱氧核苷酸(CpG ODN)对BALB/c小鼠皮下种植性乳腺癌的治疗作用及对荷瘤鼠免疫功能的影响.方法 32只BALB/c小鼠双侧胁肋部皮下接种乳腺癌细胞EMT-6,建立乳腺癌动物模型,随机分为4组,每组8只,分别给予左侧皮下肿瘤射频消融+瘤周注射CpG ODN、射频消融、瘤周注射CpG ODN和瘤周注射生理盐水4种处理.定期测量治疗侧及非治疗侧肿瘤大小,尾静脉取血法收集各组小鼠外周血,酶联免疫吸附试验(ELISA)法检测血清白细胞介素(IL)-12、IL-10、IL-2及干扰素(IFN)-γ含量.当非治疗侧肿瘤直径达到18mm时手术切除肿瘤,并记录为非治疗侧观察终点,当治疗侧肿瘤直径达到18 mm时或出现恶病质时处死小鼠,记录生存时间.结果 射频消融+瘤周注射CpG ODN组和射频消融组治疗侧肿瘤体积体积显著小于CpG ODN组和对照组(P<0.05).射频消融+瘤周注射CpG ODN组未治疗侧的肿瘤体积在第21天后明显小于其他各组(P<0.05).射频消融+瘤周注射CpG ODN组中位生存时间为92 d,射频消融组为84d,瘤周注射CpG ODN组为64d,对照组为60d.射频消融+瘤周注射CpG ODN组小鼠外周血中IL-12浓度为312.40 ng/L,IL-10浓度为216.34 ng/L,IL-2浓度为75.33 ng/L,IFN-γ浓度为69.32 ng/L,显著高于其他3组(P<0.05).结论 射频消融联合瘤周注射CpG ODN能激活小鼠体内的抗肿瘤免疫效应,起到抑制肿瘤生长作用.
目的 觀察射頻消融聯閤瘤週註射胞嘧啶鳥嘌呤寡脫氧覈苷痠(CpG ODN)對BALB/c小鼠皮下種植性乳腺癌的治療作用及對荷瘤鼠免疫功能的影響.方法 32隻BALB/c小鼠雙側脅肋部皮下接種乳腺癌細胞EMT-6,建立乳腺癌動物模型,隨機分為4組,每組8隻,分彆給予左側皮下腫瘤射頻消融+瘤週註射CpG ODN、射頻消融、瘤週註射CpG ODN和瘤週註射生理鹽水4種處理.定期測量治療側及非治療側腫瘤大小,尾靜脈取血法收集各組小鼠外週血,酶聯免疫吸附試驗(ELISA)法檢測血清白細胞介素(IL)-12、IL-10、IL-2及榦擾素(IFN)-γ含量.噹非治療側腫瘤直徑達到18mm時手術切除腫瘤,併記錄為非治療側觀察終點,噹治療側腫瘤直徑達到18 mm時或齣現噁病質時處死小鼠,記錄生存時間.結果 射頻消融+瘤週註射CpG ODN組和射頻消融組治療側腫瘤體積體積顯著小于CpG ODN組和對照組(P<0.05).射頻消融+瘤週註射CpG ODN組未治療側的腫瘤體積在第21天後明顯小于其他各組(P<0.05).射頻消融+瘤週註射CpG ODN組中位生存時間為92 d,射頻消融組為84d,瘤週註射CpG ODN組為64d,對照組為60d.射頻消融+瘤週註射CpG ODN組小鼠外週血中IL-12濃度為312.40 ng/L,IL-10濃度為216.34 ng/L,IL-2濃度為75.33 ng/L,IFN-γ濃度為69.32 ng/L,顯著高于其他3組(P<0.05).結論 射頻消融聯閤瘤週註射CpG ODN能激活小鼠體內的抗腫瘤免疫效應,起到抑製腫瘤生長作用.
목적 관찰사빈소융연합류주주사포밀정조표령과탈양핵감산(CpG ODN)대BALB/c소서피하충식성유선암적치료작용급대하류서면역공능적영향.방법 32지BALB/c소서쌍측협륵부피하접충유선암세포EMT-6,건립유선암동물모형,수궤분위4조,매조8지,분별급여좌측피하종류사빈소융+류주주사CpG ODN、사빈소융、류주주사CpG ODN화류주주사생리염수4충처리.정기측량치료측급비치료측종류대소,미정맥취혈법수집각조소서외주혈,매련면역흡부시험(ELISA)법검측혈청백세포개소(IL)-12、IL-10、IL-2급간우소(IFN)-γ함량.당비치료측종류직경체도18mm시수술절제종류,병기록위비치료측관찰종점,당치료측종류직경체도18 mm시혹출현악병질시처사소서,기록생존시간.결과 사빈소융+류주주사CpG ODN조화사빈소융조치료측종류체적체적현저소우CpG ODN조화대조조(P<0.05).사빈소융+류주주사CpG ODN조미치료측적종류체적재제21천후명현소우기타각조(P<0.05).사빈소융+류주주사CpG ODN조중위생존시간위92 d,사빈소융조위84d,류주주사CpG ODN조위64d,대조조위60d.사빈소융+류주주사CpG ODN조소서외주혈중IL-12농도위312.40 ng/L,IL-10농도위216.34 ng/L,IL-2농도위75.33 ng/L,IFN-γ농도위69.32 ng/L,현저고우기타3조(P<0.05).결론 사빈소융연합류주주사CpG ODN능격활소서체내적항종류면역효응,기도억제종류생장작용.
Objective To investigate the efficacy of microwave ablation combined with peritumoral injected cytosine phosphate guanine oligodeoxyribonucleotide (CpG ODN) in inducing immunityresponse against mouse breast cancer.Methods Bilateral breast cancer model was established by subcutaneous injection EMT-6 cells underneath both sides of the BALB/c mouse rib area.According the therapy method to the left side tumor,there were 32 mice were divided randomly into four groups:combination therapy group (microwave ablation combined with peritumoral injected CpG ODN),ablation therapy group,CpG ODN therapy group,and control group.Bilateral tumor volume and survive time were observed.Concentration of interleukin (IL)-12,IL-10,IL-2 and interferon (IFN)-γ in serum were detected by enzyme linked immunosorbent assay (ELISA) method.When the non-treatment side tumor reaches 18 mm in diameter,the tumor resection is carried on,and recorded as endpoint of this side.When the treatment side tumor reaches 18 mm in diameter or cachexia takes place,the mice will be killed and the survival time will be recorded.Results In the bilateral tumor model,the left tumor volumes in combination therapygroup and ablation therapy group were smaller than those in CpG ODN therapy group and control group,right tumor volumes in combination therapygroup were smaller than those in other group after 21 days.The median survive time in combination therapy group,ablation therapy group,CpG ODN therapy group,and control group were 92,84,64,60 days respectively.The serum concentrations of IL-2,IL-10,IL-12,IFN-γin combination therapy group were higher than those in other groups.Conclusion Microwave ablation combined with peritumoralinjection of CpG ODN can enhance the host antitumor immunityeffect and inhibit tumor growth.